Eczema: quality of life by body site and the effect of patch testing
Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results...
Gespeichert in:
Veröffentlicht in: | British journal of dermatology (1951) 2002-04, Vol.146 (4), p.627-630 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 630 |
---|---|
container_issue | 4 |
container_start_page | 627 |
container_title | British journal of dermatology (1951) |
container_volume | 146 |
creator | Thomson, K.F. Wilkinson, S.M. Sommer, S. Pollock, B. |
description | Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests.
Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site.
Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other).
Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P |
doi_str_mv | 10.1046/j.1365-2133.2002.04692.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71615454</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>125366191</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</originalsourceid><addsrcrecordid>eNqNkMtu1DAYhS0EotOWV0AWEt0l-H5BYtEbLagtGy4SG8txbOohk0zjREz69HWYUSuxYmXL_r7z_zoAQIxKjJh4tywxFbwgmNKSIETK_KhJuXkGFo8fz8ECISQLpAXdA_spLRHCFHH0EuxhrIUQmi3A2bm79yv7Ht6NtonDBLsAmxg8rCZYdfUEUxw8tG0Nh1sPfQjeDTOztoO7hYNPQ2x_HYIXwTbJv9qdB-Dbx_Ovp5fF1ZeLT6fHV4VjApEiaEdY0Miximqpa4kCQ04ppDyvpOWkltoqxq2qRC25ZTJQqwKTjkvJZUUPwNE2d913d2OebVYxOd80tvXdmIzEAnPGWQbf_AMuu7Fv824m14UxZQpnSG0h13cp9T6YdR9Xtp8MRmau2SzN3KaZ25w9Yv7WbDZZfb3LH6uVr5_EXa8ZeLsDbHK2Cb1tXUxPXI6lWpHMfdhyf2Ljp_9ewJx8Pptv2S-2fkyD3zz6tv9thKSSmx83F0ZeXt_Ik5_EfKcPKqSkrw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200113481</pqid></control><display><type>article</type><title>Eczema: quality of life by body site and the effect of patch testing</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</creator><creatorcontrib>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</creatorcontrib><description>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests.
Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site.
Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other).
Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P < 0·0001).
Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1046/j.1365-2133.2002.04692.x</identifier><identifier>PMID: 11966694</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adolescent ; Adult ; Aged ; Allergic diseases ; Biological and medical sciences ; body site ; contact allergy ; Dermatitis, Allergic Contact - diagnosis ; Dermatitis, Allergic Contact - pathology ; Dermatitis, Allergic Contact - rehabilitation ; eczema ; Eczema - pathology ; Eczema - rehabilitation ; Female ; Follow-Up Studies ; Humans ; Immunopathology ; Linear Models ; Male ; Medical sciences ; Middle Aged ; Patch Tests ; Quality of Life ; Severity of Illness Index ; Skin allergic diseases. Stinging insect allergies</subject><ispartof>British journal of dermatology (1951), 2002-04, Vol.146 (4), p.627-630</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Apr 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</citedby><cites>FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2133.2002.04692.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2133.2002.04692.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,27929,27930,45579,45580</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13653982$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11966694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomson, K.F.</creatorcontrib><creatorcontrib>Wilkinson, S.M.</creatorcontrib><creatorcontrib>Sommer, S.</creatorcontrib><creatorcontrib>Pollock, B.</creatorcontrib><title>Eczema: quality of life by body site and the effect of patch testing</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests.
Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site.
Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other).
Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P < 0·0001).
Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Allergic diseases</subject><subject>Biological and medical sciences</subject><subject>body site</subject><subject>contact allergy</subject><subject>Dermatitis, Allergic Contact - diagnosis</subject><subject>Dermatitis, Allergic Contact - pathology</subject><subject>Dermatitis, Allergic Contact - rehabilitation</subject><subject>eczema</subject><subject>Eczema - pathology</subject><subject>Eczema - rehabilitation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Linear Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Patch Tests</subject><subject>Quality of Life</subject><subject>Severity of Illness Index</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkMtu1DAYhS0EotOWV0AWEt0l-H5BYtEbLagtGy4SG8txbOohk0zjREz69HWYUSuxYmXL_r7z_zoAQIxKjJh4tywxFbwgmNKSIETK_KhJuXkGFo8fz8ECISQLpAXdA_spLRHCFHH0EuxhrIUQmi3A2bm79yv7Ht6NtonDBLsAmxg8rCZYdfUEUxw8tG0Nh1sPfQjeDTOztoO7hYNPQ2x_HYIXwTbJv9qdB-Dbx_Ovp5fF1ZeLT6fHV4VjApEiaEdY0Miximqpa4kCQ04ppDyvpOWkltoqxq2qRC25ZTJQqwKTjkvJZUUPwNE2d913d2OebVYxOd80tvXdmIzEAnPGWQbf_AMuu7Fv824m14UxZQpnSG0h13cp9T6YdR9Xtp8MRmau2SzN3KaZ25w9Yv7WbDZZfb3LH6uVr5_EXa8ZeLsDbHK2Cb1tXUxPXI6lWpHMfdhyf2Ljp_9ewJx8Pptv2S-2fkyD3zz6tv9thKSSmx83F0ZeXt_Ik5_EfKcPKqSkrw</recordid><startdate>200204</startdate><enddate>200204</enddate><creator>Thomson, K.F.</creator><creator>Wilkinson, S.M.</creator><creator>Sommer, S.</creator><creator>Pollock, B.</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200204</creationdate><title>Eczema: quality of life by body site and the effect of patch testing</title><author>Thomson, K.F. ; Wilkinson, S.M. ; Sommer, S. ; Pollock, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4602-f9c24f90c4b3979d70f40c8808e5b7a52d79a845a8b6d75a47f3a8f47c57757b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Allergic diseases</topic><topic>Biological and medical sciences</topic><topic>body site</topic><topic>contact allergy</topic><topic>Dermatitis, Allergic Contact - diagnosis</topic><topic>Dermatitis, Allergic Contact - pathology</topic><topic>Dermatitis, Allergic Contact - rehabilitation</topic><topic>eczema</topic><topic>Eczema - pathology</topic><topic>Eczema - rehabilitation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Linear Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Patch Tests</topic><topic>Quality of Life</topic><topic>Severity of Illness Index</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomson, K.F.</creatorcontrib><creatorcontrib>Wilkinson, S.M.</creatorcontrib><creatorcontrib>Sommer, S.</creatorcontrib><creatorcontrib>Pollock, B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomson, K.F.</au><au>Wilkinson, S.M.</au><au>Sommer, S.</au><au>Pollock, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Eczema: quality of life by body site and the effect of patch testing</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>2002-04</date><risdate>2002</risdate><volume>146</volume><issue>4</issue><spage>627</spage><epage>630</epage><pages>627-630</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>Summary Background Patients with dermatitis are known to have impaired quality of life. Whether this varies according to body site has not been evaluated. Patch tests have previously been shown to influence quality of life, although no previous studies have shown if this is dependent on the results of the patch tests.
Objectives To evaluate the impact of patch testing on quality of life according to the outcome of the investigations and to determine how quality of life varies according to eczema body site.
Methods One hundred and sixty consecutive adult patients with active eczema were selected from a patch test clinic for inclusion into the study. Quality of life was determined using the Dermatology Life Quality Index (DLQI) and the SF‐36, prior to patch testing and 2 months later. Perceived eczema severity at each time point was also noted, along with the outcome of patch testing. Baseline comparison of quality of life was performed between four body site groups (face, hand, generalized, other).
Results Patients confirmed as having relevant positive contact allergens were shown to have a significant improvement in both perceived eczema severity (P = 0·0004) and DLQI score (P = 0·0015) at 2 months after patch testing. No significant changes were noted in the SF‐36 score, other than a borderline improvement in the pain score (P = 0·048). The improvement in quality of life and eczema severity was not noted in patients with negative patch tests. Eighty‐nine per cent of patients diagnosed as having contact allergy were able to comply with avoidance advice. No significant variation was noted in quality of life according to body site affected by eczema. There was a positive correlation between DLQI score and perceived eczema severity (P < 0·0001).
Conclusions Patients confirmed as having contact allergy show a subsequent improvement in eczema severity and an improvement in quality of life.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>11966694</pmid><doi>10.1046/j.1365-2133.2002.04692.x</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0007-0963 |
ispartof | British journal of dermatology (1951), 2002-04, Vol.146 (4), p.627-630 |
issn | 0007-0963 1365-2133 |
language | eng |
recordid | cdi_proquest_miscellaneous_71615454 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE; Oxford University Press Journals All Titles (1996-Current) |
subjects | Adolescent Adult Aged Allergic diseases Biological and medical sciences body site contact allergy Dermatitis, Allergic Contact - diagnosis Dermatitis, Allergic Contact - pathology Dermatitis, Allergic Contact - rehabilitation eczema Eczema - pathology Eczema - rehabilitation Female Follow-Up Studies Humans Immunopathology Linear Models Male Medical sciences Middle Aged Patch Tests Quality of Life Severity of Illness Index Skin allergic diseases. Stinging insect allergies |
title | Eczema: quality of life by body site and the effect of patch testing |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T04%3A09%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Eczema:%20quality%20of%20life%20by%20body%20site%20and%20the%20effect%20of%20patch%20testing&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=Thomson,%20K.F.&rft.date=2002-04&rft.volume=146&rft.issue=4&rft.spage=627&rft.epage=630&rft.pages=627-630&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1046/j.1365-2133.2002.04692.x&rft_dat=%3Cproquest_cross%3E125366191%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200113481&rft_id=info:pmid/11966694&rfr_iscdi=true |